Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline added to corticosteroid therapy in severe alcoholic hepatitis
2006-006944-78Phase 3Completed
- Sponsor
- CHU de Lille
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pentoxifylline in alcoholic hepatitis (AH) (2 arms), sponsored by CHU de Lille. Primary endpoint: 6-month survival. Started Apr 2007; status: completed.
02
Drugs
pentoxifylline
03
Conditions
alcoholic hepatitis (AH)
Beyond the preview
Go deeper on 2006-006944-78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006944-78.